Education
About Us
Working with TipRanks
Follow Us
Fusen Pharmaceutical Co., Ltd. (HK:1652)
:1652
RESEARCH TOOLSreports
Total Valuation
Fusen Pharmaceutical Co., Ltd. has a market cap or net worth of HK$246.30M. The enterprise value is HK$3.31B.
Market CapHK$246.30M
Enterprise ValueHK$3.31B
Share Statistics
Fusen Pharmaceutical Co., Ltd. has 739,301,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding739,301,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Fusen Pharmaceutical Co., Ltd.’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -8.84%.
Return on Equity (ROE)-0.51
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-8.84%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee288.27K
Profits Per Employee-166.92K
Employee Count1,131
Asset Turnover0.26
Inventory Turnover1.19
Valuation Ratios
The current PE Ratio of Fusen Pharmaceutical Co., Ltd. is -2.95. Fusen Pharmaceutical Co., Ltd.’s PEG ratio is -1.16.
PE Ratio-2.95
PS Ratio0.00
PB Ratio5.09
Price to Fair Value1.50
Price to FCF-19.07
Price to Operating Cash Flow168.23
PEG Ratio-1.16
Income Statement
In the last 12 months, Fusen Pharmaceutical Co., Ltd. had revenue of 326.03M and earned -188.78M in profits. Earnings per share was -0.26.
Revenue326.03M
Gross Profit162.64M
Operating Income-67.51M
Pretax Income-190.45M
Net Income-188.78M
EBITDA-39.07M
Earnings Per Share (EPS)-0.26
Cash Flow
In the last 12 months, operating cash flow was -6.26M and capital expenditures -45.99M, giving a free cash flow of -52.26M billion.
Operating Cash Flow-6.26M
Free Cash Flow-52.26M
Free Cash Flow per Share-0.07
Dividends & Yields
Fusen Pharmaceutical Co., Ltd. pays an annual dividend of HK$0.004, resulting in a dividend yield of ―
Dividend Per ShareHK$0.004
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.05
52-Week Price Change-70.94%
50-Day Moving Average0.30
200-Day Moving Average0.64
Relative Strength Index (RSI)51.61
Average Volume (3m)328.79K
Important Dates
Fusen Pharmaceutical Co., Ltd. upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateJun 07, 2022
Financial Position
Fusen Pharmaceutical Co., Ltd. as a current ratio of 0.60, with Debt / Equity ratio of 31.18%
Current Ratio0.60
Quick Ratio0.42
Debt to Market Cap0.69
Net Debt to EBITDA-9.28
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Fusen Pharmaceutical Co., Ltd. has paid 1.65M in taxes.
Income Tax1.65M
Effective Tax Rate>-0.01
Enterprise Valuation
Fusen Pharmaceutical Co., Ltd. EV to EBITDA ratio is -23.51, with an EV/FCF ratio of 0.00.
EV to Sales2.82
EV to EBITDA-23.51
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Fusen Pharmaceutical Co., Ltd. has HK$21.06M in cash and marketable securities with ¥383.69M in debt, giving a net cash position of HK$362.64M billion.
Cash & Marketable SecuritiesHK$21.06M
Total Debt¥383.69M
Net CashHK$362.64M
Net Cash Per ShareHK$0.49
Tangible Book Value Per ShareHK$0.46
Margins
Gross margin is 52.16%, with operating margin of -20.71%, and net profit margin of -57.90%.
Gross Margin52.16%
Operating Margin-20.71%
Pretax Margin-58.41%
Net Profit Margin-57.90%
EBITDA Margin-11.98%
EBIT Margin-20.60%
Analyst Forecast
The average price target for Fusen Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-43.73%
EPS Growth Forecast-434.17%